Abstract: An information processing device includes a processor configured to provide an incentive to a first user who sells or returns a first vehicle in which a part of a first coating film including an easily peelable layer is not peeled off.

Abstract: Aqueous pharmaceutical compositions containing a fusion protein of an antibody and a lysosomal enzyme as an active ingredient, which are stable enough to be marketed, are disclosed. The aqueous pharmaceutical composition, for example, comprises the fusion protein of the antibody and the lysosomal enzyme at a concentration of 0.5 to 20 mg/mL, sodium chloride at a concentration of 0.3 to 1.2 mg/mL, sucrose at a concentration of 50 to 100 mg/mL, a nonionic surfactant at a concentration of 0.15 to 3 mg/mL, a buffer at a concentration of 3 to 30 mM, and is adjusted to pH 5.0 to 7.5.

Abstract: A system for collecting, storing, and dispensing breastmilk can include stackable containers with various shaped lids and bottles that are shaped complementary to each other to provide stability to the stacked container assembly. In some examples, the lids and bottle also include attachment features that engage with each other to secure a bottle of a top container to the lid of a bottom container.

Abstract: The present invention discloses an aqueous pharmaceutical composition containing a protein in which serum albumin and growth hormone are linked. The aqueous pharmaceutical composition contains, as an active ingredient, a fusion protein of human serum albumin and human growth hormone; the concentration of the fusion protein is 10-100 mg/mL; the concentration of sucrose is 10-150 mg/mL; the concentration of a nonionic surfactant is 0.15-10 mg/mL; the concentration of a preservative is 0.5-12 mg/mL; the concentration of a buffer is 1-30 mM; and the pH is 5.0-8.0.

Abstract: A breastmilk collection device includes breast contacting flange, a vacuum reservoir, flexible diaphragm separating the breast contacting flange and the vacuum reservoir, and a flange receiver between the breast contacting flange and the flexible diaphragm. The breast contacting flange has a wide portion for accepting the breast and a narrow portion. The flexible diaphragm is located between the narrow portion and the vacuum reservoir. The flexible diaphragm moves between a sealed configuration, in which the breast contacting flange is sealed off from the vacuum reservoir, and an open valve configuration, in which the flexible diaphragm acts as a one-way valve to allow expressed milk to flow through a milk flow opening between the flexible diaphragm and the breast contacting flange when an opening pressure is reached in the breast contacting flange.

Abstract: A wearable breastmilk collection device includes a storage compartment with a flange and a cup, a breast accepting flange separated from the storage compartment by a one-way valve, a vacuum source attachment, and a reservoir in communication with the vacuum source attachment. A method of expressing and collecting breastmilk from a breast may involve using the wearable breastmilk collection device described above to express breastmilk from the breast, while the device is positioned in the woman's brassiere.

Abstract: A breastmilk collection device includes breast contacting flange, a vacuum reservoir, flexible diaphragm separating the breast contacting flange and the vacuum reservoir, and a flange receiver between the breast contacting flange and the flexible diaphragm. The breast contacting flange has a wide portion for accepting the breast and a narrow portion. The flexible diaphragm is located between the narrow portion and the vacuum reservoir. The flexible diaphragm moves between a sealed configuration, in which the breast contacting flange is sealed off from the vacuum reservoir, and an open valve configuration, in which the flexible diaphragm acts as a one-way valve to allow expressed milk to flow through a milk flow opening between the flexible diaphragm and the breast contacting flange when an opening pressure is reached in the breast contacting flange.

Abstract: [Problem] To provide a pharmaceutical composition containing a fusion protein comprising an antibody and a lysosomal enzyme as an active ingredient, which is stable enough to permit its distribution to the market. [Solution] A lyophilized formulation containing; a fusion protein comprising an antibody and a lysosomal enzyme as an active ingredient, and further containing a neutral salt, a disaccharide, a nonionic surfactant, and a buffer. Such a lyophilized formulation includes, for example, as an active ingredient, a fusion protein comprising an anti-transferrin receptor antibody and human iduronate-2-sulfatase, and further containing sodium chloride as the neutral salt, sucrose as the disaccharide, poloxamer as the nonionic surfactant, and phosphate buffer as the buffer.

Abstract: [Problem] To provide a pharmaceutical composition containing a fusion protein comprising an antibody and a lysosomal enzyme as an active ingredient, which is stable enough to permit its distribution to the market. [Solution] A lyophilized formulation containing; a fusion protein comprising an antibody and a lysosomal enzyme as an active ingredient, and further containing a neutral salt, a disaccharide, a nonionic surfactant, and a buffer. Such a lyophilized formulation includes, for example, as an active ingredient, a fusion protein comprising an anti-transferrin receptor antibody and human iduronate-2-sulfatase, and further containing sodium chloride as the neutral salt, sucrose as the disaccharide, poloxamer as the nonionic surfactant, and phosphate buffer as the buffer.

Abstract: Aqueous pharmaceutical compositions containing a fusion protein of an antibody and a lysosomal enzyme as an active ingredient, which are stable enough to be marketed, are disclosed. The aqueous pharmaceutical composition, for example, comprises the fusion protein of the antibody and the lysosomal enzyme at a concentration of 0.5 to 20 mg/mL, sodium chloride at a concentration of 0.3 to 1.2 mg/mL, sucrose at a concentration of 50 to 100 mg/mL, a nonionic surfactant at a concentration of 0.15 to 3 mg/mL, a buffer at a concentration of 3 to 30 mM, and is adjusted to pH 5.0 to 7.5.

Abstract: [Problem] To provide a pharmaceutical composition containing a fusion protein comprising an antibody and a lysosomal enzyme as an active ingredient, which is stable enough to permit its distribution to the market. [Solution] A lyophilized formulation containing; a fusion protein comprising an antibody and a lysosomal enzyme as an active ingredient, and further containing a neutral salt, a disaccharide, a nonionic surfactant, and a buffer. Such a lyophilized formulation includes, for example, as an active ingredient, a fusion protein comprising an anti-transferrin receptor antibody and human iduronate-2-sulfatase, and further containing sodium chloride as the neutral salt, sucrose as the disaccharide, poloxamer as the nonionic surfactant, and phosphate buffer as the buffer.

Abstract: Provided is a water treatment system that prevents overlook and misdetection of abnormal flocculation. The water treatment system includes a mix tank, a flocculation tank, a plurality of floc-particle-diameter measurement devices, a fault detection device that detects abnormal flocculation, and a notification device that notifies occurrence of the abnormal flocculation. The fault detection device includes: a calculator that calculates at least one of a difference and a ratio between particle diameters of floc; a storage that stores therein a tolerable range of at least one of the difference and the ratio between the particle diameters of floc; a determiner that, when the calculated value is within the tolerable range, determines that it is normal, and when the calculated value is outside the tolerable range, determines that it is abnormal; and an outputter that transmits an abnormal flocculation detection signal to the notification device.

Abstract: Provided is a water treatment system that prevents overlook and misdetection of abnormal flocculation. The water treatment system includes a mix tank, a flocculation tank, a plurality of floc-particle-diameter measurement devices, a fault detection device that detects abnormal flocculation, and a notification device that notifies occurrence of the abnormal flocculation. The fault detection device includes: a calculator that calculates at least one of a difference and a ratio between particle diameters of floc; a storage that stores therein a tolerable range of at least one of the difference and the ratio between the particle diameters of floc; a determiner that, when the calculated value is within the tolerable range, determines that it is normal, and when the calculated value is outside the tolerable range, determines that it is abnormal; and an outputter that transmits an abnormal flocculation detection signal to the notification device.

Abstract: A game providing system according to an embodiment of the present invention includes one or more processors capable of executing a game program. In one embodiment, the game program includes a conversion rate presentation module configured to present a conversion rate between a first basic point and a first varying point to a player. When a first basic object associated with the first basic point is selected, an acquired point of the player is determined on the basis of the first basic point. When a first varying object associated with the first varying point is selected, the acquired point is determined on the basis of the first varying point.

Abstract: A game providing system according to an embodiment of the present invention includes one or more processors capable of executing a game program. In one embodiment, the game program includes a conversion rate presentation module configured to present a conversion rate between a first basic point and a first varying point to a player. When a first basic object associated with the first basic point is selected, an acquired point of the player is determined on the basis of the first basic point. When a first varying object associated with the first varying point is selected, the acquired point is determined on the basis of the first varying point.

Abstract: A cleaning device of this invention has a first cleaning member that is provided opposing to a developer image carrier for the scraping of the surface of the developer image carrier and a second cleaning member that is put over the first cleaning member and runs between the surface of the developer image carrier and the first cleaning member for the wiping of the surface of the developer image carrier simultaneously with the scraping of the surface of the developer image carrier by the first cleaning member. This cleaning device is used for cleaning of the developer image carrier of an image forming apparatus.

Abstract: A cleaning device of this invention has a first cleaning member that is provided opposing to a developer image carrier for the scraping of the surface of the developer image carrier and a second cleaning member that is put over the first cleaning member and runs between the surface of the developer image carrier and the first cleaning member for the wiping of the surface of the developer image carrier simultaneously with the scraping of the surface of the developer image carrier by the first cleaning member. This cleaning device is used for cleaning of the developer image carrier of an image forming apparatus.

Abstract: A cleaning device of this invention has a first cleaning member that is provided opposing to a developer image carrier for the scraping of the surface of the developer image carrier and a second cleaning member that is put over the first cleaning member and runs between the surface of the developer image carrier and the first cleaning member for the wiping of the surface of the developer image carrier simultaneously with the scraping of the surface of the developer image carrier by the first cleaning member. This cleaning device is used for cleaning of the developer image carrier of an image forming apparatus.

Abstract: A cleaning device of this invention has a first cleaning member that is provided opposing to a developer image carrier for the scraping of the surface of the developer image carrier and a second cleaning member that is put over the first cleaning member and runs between the surface of the developer image carrier and the first cleaning member for the wiping of the surface of the developer image carrier simultaneously with the scraping of the surface of the developer image carrier by the first cleaning member. This cleaning device is used for cleaning of the developer image carrier of an image forming apparatus.

Abstract: An image forming apparatus includes a latent image forming mechanism for forming an electrostatic latent image on a photosensitive member, and a developing device for supplying a developing liquid containing at least toner and a carrier liquid, to the photosensitive member on which the latent image is formed, thereby to develop the latent image. The image forming apparatus also includes a removing device for removing an excessive portion of the developing liquid supplied by the developing device, whereby the excessive portion of the developing liquid remains on the photosensitive member after development. The image forming apparatus further includes a returning mechanism for returning the excessive portion of the developing liquid, which is removed by the removing device, into a casing of a developing liquid supply unit for supplying the developing liquid to the developing device, and a reserve flow-in section.